AstraZeneca has announced a £300 million investment into the UK’s life sciences sector, providing a boost to jobs and research development. However, global businesses are facing pressure as supply chains are disrupted by geopolitical tensions.\n\nMajor brands have warned of logistical difficulties, highlighting broader issues affecting global retail and distribution. UK banks have reported mixed financial results, reflecting uncertainty in the wider economy.
Business Resilience in an Era of AI and Geopolitical Change
Businesses continue adapting to an environment shaped by geopolitical uncertainty and rapid technological change. Artificial intelligence remains one of the strongest growth sectors, with companies investing heavily in automation, cloud…
